Literature DB >> 22412600

3-Benzyl-6-methyl-2-sulfanylidene-2,3-di-hydroquinazolin-4(1H)-one.

Rashad Al-Salahi, Mohamed Al-Omar, Hussein El-Subbagh, Madhukar Hemamalini, Hoong-Kun Fun.   

Abstract

In the title compound, C(16)H(14)N(2)OS, the quinazoline ring system is essentially planar, with a maximum deviation of 0.029 (3) Å. The dihedral angle between the quinazoline and benzene rings is 88.4 (2)°. In the crystal, adjacent mol-ecules are connected via pairs of N-H⋯S and C-H⋯O hydrogen bonds, which generate R(2) (2)(8) and R(2) (2)(10) graph-set motifs, respectively, resulting in a supra-molecular chain along the a axis.

Entities:  

Year:  2012        PMID: 22412600      PMCID: PMC3295489          DOI: 10.1107/S1600536812006009

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For details and applications of quinazoline compounds, see: Roth & Fenner (2000 ▶); Jantova et al. (2004 ▶); Harris & Thorarensen (2004 ▶); Andries et al. (2005 ▶); Al-Rashood et al. (2006 ▶); Ghorab et al. (2007 ▶); Rádl et al. (2000 ▶); Klepser & Klepser (1997 ▶); Al-Omar et al. (2004 ▶); Al-Omary et al. (2010 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶). For bond-length data, see: Allen et al. (1987 ▶).

Experimental

Crystal data

C16H14N2OS M = 282.35 Monoclinic, a = 24.2438 (18) Å b = 5.1618 (5) Å c = 24.4265 (17) Å β = 111.532 (6)° V = 2843.4 (4) Å3 Z = 8 Cu Kα radiation μ = 1.99 mm−1 T = 296 K 0.83 × 0.12 × 0.06 mm

Data collection

Bruker SMART APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.289, T max = 0.890 9528 measured reflections 2592 independent reflections 1421 reflections with I > 2σ(I) R int = 0.104

Refinement

R[F 2 > 2σ(F 2)] = 0.055 wR(F 2) = 0.166 S = 0.93 2592 reflections 182 parameters H-atom parameters constrained Δρmax = 0.24 e Å−3 Δρmin = −0.21 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536812006009/is5070sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812006009/is5070Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812006009/is5070Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C16H14N2OSF(000) = 1184
Mr = 282.35Dx = 1.319 Mg m3
Monoclinic, C2/cCu Kα radiation, λ = 1.54178 Å
Hall symbol: -C 2ycCell parameters from 339 reflections
a = 24.2438 (18) Åθ = 3.9–53.5°
b = 5.1618 (5) ŵ = 1.99 mm1
c = 24.4265 (17) ÅT = 296 K
β = 111.532 (6)°Needle, colourless
V = 2843.4 (4) Å30.83 × 0.12 × 0.06 mm
Z = 8
Bruker SMART APEXII CCD diffractometer2592 independent reflections
Radiation source: fine-focus sealed tube1421 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.104
φ and ω scansθmax = 69.8°, θmin = 3.9°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −29→29
Tmin = 0.289, Tmax = 0.890k = −6→5
9528 measured reflectionsl = −28→28
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.055Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.166H-atom parameters constrained
S = 0.93w = 1/[σ2(Fo2) + (0.0875P)2] where P = (Fo2 + 2Fc2)/3
2592 reflections(Δ/σ)max = 0.001
182 parametersΔρmax = 0.24 e Å3
0 restraintsΔρmin = −0.21 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.22029 (4)0.1447 (2)0.07055 (4)0.0718 (3)
N10.17921 (10)0.4985 (6)−0.01167 (11)0.0630 (7)
H1A0.20970.4590−0.01990.076*
N20.12318 (10)0.4401 (5)0.04598 (11)0.0574 (7)
O10.04534 (10)0.7057 (5)0.03541 (11)0.0747 (7)
C10.17206 (13)0.3706 (7)0.03308 (14)0.0594 (8)
C20.08423 (13)0.6424 (7)0.01808 (14)0.0600 (8)
C30.09395 (12)0.7664 (7)−0.03127 (13)0.0585 (8)
C40.05611 (13)0.9575 (7)−0.06444 (14)0.0630 (9)
H4A0.02431.0100−0.05440.076*
C50.06438 (15)1.0717 (7)−0.11196 (15)0.0691 (9)
C60.11382 (16)0.9891 (8)−0.12434 (16)0.0763 (10)
H6A0.12061.0638−0.15590.092*
C70.15210 (15)0.8048 (7)−0.09221 (15)0.0715 (10)
H7A0.18480.7578−0.10130.086*
C80.14201 (13)0.6879 (7)−0.04573 (14)0.0578 (8)
C90.10920 (14)0.2997 (7)0.09172 (15)0.0657 (9)
H9A0.12630.12760.09580.079*
H9B0.06650.27990.07880.079*
C100.13111 (14)0.4281 (7)0.15093 (14)0.0641 (9)
C110.1103 (2)0.3376 (10)0.1930 (2)0.0988 (15)
H11A0.08310.20220.18400.119*
C120.1298 (3)0.4483 (15)0.2483 (2)0.131 (2)
H12A0.11440.39020.27580.157*
C130.1710 (3)0.6401 (16)0.2634 (2)0.133 (2)
H13A0.18540.70570.30150.160*
C140.1912 (2)0.7364 (11)0.2216 (2)0.1082 (15)
H14A0.21790.87370.23060.130*
C150.17129 (17)0.6268 (8)0.16567 (16)0.0783 (11)
H15A0.18560.68980.13770.094*
C160.02217 (18)1.2711 (9)−0.14931 (18)0.0893 (12)
H16B−0.00641.3143−0.13210.134*
H16A0.00211.2027−0.18810.134*
H16C0.04381.4238−0.15160.134*
U11U22U33U12U13U23
S10.0640 (5)0.0875 (7)0.0707 (6)0.0172 (4)0.0327 (5)0.0084 (5)
N10.0558 (14)0.083 (2)0.0576 (17)0.0153 (13)0.0295 (14)0.0029 (15)
N20.0510 (13)0.0688 (18)0.0577 (16)0.0036 (11)0.0264 (13)−0.0049 (13)
O10.0601 (12)0.0924 (19)0.0855 (17)0.0135 (11)0.0430 (13)−0.0007 (13)
C10.0500 (16)0.076 (2)0.0554 (19)0.0024 (14)0.0231 (16)−0.0121 (17)
C20.0498 (16)0.073 (2)0.059 (2)0.0022 (14)0.0228 (16)−0.0124 (17)
C30.0472 (16)0.076 (2)0.051 (2)−0.0010 (14)0.0169 (16)−0.0104 (17)
C40.0543 (17)0.070 (2)0.066 (2)0.0069 (15)0.0225 (17)−0.0068 (18)
C50.065 (2)0.074 (2)0.066 (2)0.0057 (16)0.0211 (18)−0.0006 (19)
C60.077 (2)0.086 (3)0.072 (2)0.0089 (18)0.035 (2)0.008 (2)
C70.068 (2)0.090 (3)0.068 (2)0.0134 (17)0.0375 (19)0.009 (2)
C80.0472 (16)0.073 (2)0.0540 (19)0.0062 (13)0.0194 (15)−0.0060 (16)
C90.0629 (19)0.065 (2)0.080 (2)−0.0013 (14)0.0393 (19)−0.0001 (18)
C100.0643 (18)0.074 (2)0.063 (2)0.0196 (16)0.0343 (18)0.0090 (18)
C110.115 (3)0.114 (4)0.090 (3)0.020 (3)0.065 (3)0.028 (3)
C120.150 (6)0.185 (7)0.080 (4)0.064 (5)0.069 (4)0.043 (4)
C130.131 (5)0.196 (7)0.068 (3)0.061 (4)0.031 (4)−0.018 (4)
C140.108 (4)0.117 (4)0.092 (3)0.010 (3)0.027 (3)−0.030 (3)
C150.082 (2)0.089 (3)0.066 (3)0.002 (2)0.029 (2)−0.011 (2)
C160.082 (3)0.091 (3)0.092 (3)0.014 (2)0.028 (2)0.012 (2)
S1—C11.667 (3)C7—H7A0.9300
N1—C11.342 (4)C9—C101.500 (5)
N1—C81.382 (4)C9—H9A0.9700
N1—H1A0.8600C9—H9B0.9700
N2—C11.381 (3)C10—C151.369 (5)
N2—C21.405 (4)C10—C111.381 (5)
N2—C91.472 (4)C11—C121.382 (7)
O1—C21.212 (3)C11—H11A0.9300
C2—C31.458 (4)C12—C131.357 (9)
C3—C41.388 (5)C12—H12A0.9300
C3—C81.396 (4)C13—C141.377 (8)
C4—C51.381 (5)C13—H13A0.9300
C4—H4A0.9300C14—C151.390 (6)
C5—C61.406 (5)C14—H14A0.9300
C5—C161.501 (5)C15—H15A0.9300
C6—C71.359 (5)C16—H16B0.9600
C6—H6A0.9300C16—H16A0.9600
C7—C81.385 (4)C16—H16C0.9600
C1—N1—C8126.0 (2)N2—C9—C10114.6 (3)
C1—N1—H1A117.0N2—C9—H9A108.6
C8—N1—H1A117.0C10—C9—H9A108.6
C1—N2—C2124.2 (3)N2—C9—H9B108.6
C1—N2—C9120.1 (3)C10—C9—H9B108.6
C2—N2—C9115.7 (2)H9A—C9—H9B107.6
N1—C1—N2115.9 (3)C15—C10—C11118.5 (4)
N1—C1—S1121.1 (2)C15—C10—C9123.4 (3)
N2—C1—S1123.0 (2)C11—C10—C9118.1 (4)
O1—C2—N2120.1 (3)C10—C11—C12120.0 (5)
O1—C2—C3123.6 (3)C10—C11—H11A120.0
N2—C2—C3116.3 (2)C12—C11—H11A120.0
C4—C3—C8119.5 (3)C13—C12—C11121.3 (5)
C4—C3—C2121.5 (3)C13—C12—H12A119.3
C8—C3—C2119.0 (3)C11—C12—H12A119.3
C5—C4—C3121.7 (3)C12—C13—C14119.3 (5)
C5—C4—H4A119.1C12—C13—H13A120.4
C3—C4—H4A119.1C14—C13—H13A120.4
C4—C5—C6116.7 (3)C13—C14—C15119.5 (6)
C4—C5—C16121.8 (3)C13—C14—H14A120.3
C6—C5—C16121.5 (3)C15—C14—H14A120.3
C7—C6—C5122.9 (3)C10—C15—C14121.3 (4)
C7—C6—H6A118.5C10—C15—H15A119.3
C5—C6—H6A118.5C14—C15—H15A119.3
C6—C7—C8119.3 (3)C5—C16—H16B109.5
C6—C7—H7A120.3C5—C16—H16A109.5
C8—C7—H7A120.3H16B—C16—H16A109.5
N1—C8—C7122.0 (3)C5—C16—H16C109.5
N1—C8—C3118.3 (3)H16B—C16—H16C109.5
C7—C8—C3119.7 (3)H16A—C16—H16C109.5
C8—N1—C1—N2−0.9 (5)C1—N1—C8—C7−178.2 (3)
C8—N1—C1—S1179.7 (3)C1—N1—C8—C33.6 (5)
C2—N2—C1—N1−4.2 (5)C6—C7—C8—N1179.7 (4)
C9—N2—C1—N1176.0 (3)C6—C7—C8—C3−2.1 (6)
C2—N2—C1—S1175.1 (2)C4—C3—C8—N1179.5 (3)
C9—N2—C1—S1−4.6 (4)C2—C3—C8—N1−1.3 (5)
C1—N2—C2—O1−173.6 (3)C4—C3—C8—C71.3 (5)
C9—N2—C2—O16.1 (5)C2—C3—C8—C7−179.6 (3)
C1—N2—C2—C36.2 (5)C1—N2—C9—C1097.0 (3)
C9—N2—C2—C3−174.1 (3)C2—N2—C9—C10−82.7 (3)
O1—C2—C3—C4−4.2 (5)N2—C9—C10—C15−13.4 (5)
N2—C2—C3—C4176.0 (3)N2—C9—C10—C11167.7 (3)
O1—C2—C3—C8176.6 (3)C15—C10—C11—C120.3 (6)
N2—C2—C3—C8−3.1 (5)C9—C10—C11—C12179.3 (4)
C8—C3—C4—C50.5 (5)C10—C11—C12—C13−2.3 (8)
C2—C3—C4—C5−178.6 (3)C11—C12—C13—C143.8 (10)
C3—C4—C5—C6−1.4 (5)C12—C13—C14—C15−3.2 (8)
C3—C4—C5—C16177.6 (3)C11—C10—C15—C140.2 (6)
C4—C5—C6—C70.5 (6)C9—C10—C15—C14−178.7 (4)
C16—C5—C6—C7−178.5 (4)C13—C14—C15—C101.3 (7)
C5—C6—C7—C81.3 (6)
D—H···AD—HH···AD···AD—H···A
N1—H1A···S1i0.862.503.335 (3)165
C4—H4A···O1ii0.932.413.295 (4)159
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1A⋯S1i0.862.503.335 (3)165
C4—H4A⋯O1ii0.932.413.295 (4)159

Symmetry codes: (i) ; (ii) .

  8 in total

1.  Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.

Authors:  Sarah T Al-Rashood; Ihsan A Aboldahab; Mahmoud N Nagi; Laila A Abouzeid; Alaa A M Abdel-Aziz; Sami G Abdel-Hamide; Khairia M Youssef; Abdulrahman M Al-Obaid; Hussein I El-Subbagh
Journal:  Bioorg Med Chem       Date:  2006-09-12       Impact factor: 3.641

2.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Utility of 4-(5,5-dimethyl-3-oxo-cyclohex-1-enylamino)benzenesulfonamide in the synthesis of novel quinolines as possible anticancer and radioprotective agents.

Authors:  Mostafa M Ghorab; Fatma A Ragab; Eman Noaman; Helmy I Heiba; Ebaa M El-Hossary
Journal:  Arzneimittelforschung       Date:  2008

Review 5.  Drug treatment of HIV-related opportunistic infections.

Authors:  M E Klepser; T B Klepser
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

6.  Synthesis and analgesic activity of some quinazoline analogs of anpirtoline.

Authors:  S Rádl; P Hezky; J Proska; I Krejcí
Journal:  Arch Pharm (Weinheim)       Date:  2000-11       Impact factor: 3.751

Review 7.  Advances in the discovery of novel antibacterial agents during the year 2002.

Authors:  Christina R Harris; Atli Thorarensen
Journal:  Curr Med Chem       Date:  2004-08       Impact factor: 4.530

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  8 in total
  1 in total

1.  Synthesis and anticancer activity of new quinazoline derivatives.

Authors:  Hatem A Abuelizz; Mohamed Marzouk; Hazem Ghabbour; Rashad Al-Salahi
Journal:  Saudi Pharm J       Date:  2017-04-22       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.